Heterodox
Medicare is almost $200 billion in gross drug spend: Who gets the blame? — 46brooklyn Research This is a complex issue as there are many moving parts to drug pricing and their costs. Perplexing in describing the drug spend issues would seem appropriate. I am not even sure if this long post will adequately define the issue of how drug prices are set. However, here is another article which I believe may break this down even more so. Later on...
Read More »Medicare’s $200 billion Gross Drug Spend
